Brief: AroCell: Study Supports That TK1 Can Predict Death In Prostate Cancer

IDL Diagnostics AB (publ)

13/04/2021 14:32

April 13 (Reuters) - AroCell AB (publ)  AROC.ST :
    * A NEW STUDY SUPPORTS THAT TK1 CAN PREDICT DEATH IN
PROSTATE
CANCER
    * MORTALITY FROM PROSTATE CANCER WAS HIGHER AMONG MEN WHO
HAD A
HIGH CONCENTRATION OF TK1 IN BLOOD COMPARED TO THOSE WHO HAD A
LOW CONCENTRATION

Source text for Eikon:  ID:nMFN7tyK4D 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))